Z Pietrzkowski
Overview
Explore the profile of Z Pietrzkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Price A, de Godoy M, Harper T, Knap K, Joslyn S, Pietrzkowski Z, et al.
J Anim Sci
. 2017 Jul;
95(7):2907-2916.
PMID: 28727103
Our objective was to evaluate the short-term effects of calcium fructoborate (CFB) on gait, joint range of motion, serum inflammatory markers, and owner perception of pain in client-owned dogs. We...
2.
Drukala J, Rajwa B, Pietrzkowski Z
Anticancer Res
. 2002 Mar;
21(6A):3793-8.
PMID: 11911249
CD44H is a transmembrane protein involved in cell-cell and cell-matrix interactions. In melanoma cells CD44H influences motility and invasiveness. Daunomycin (daunorubicin) is an anthracycline antibiotic, capable to inducing apoptosis in...
3.
Pietrzkowski Z, Girardet J, Esler C, Wang G
Nucleosides Nucleotides Nucleic Acids
. 2001 Sep;
20(4-7):323-8.
PMID: 11563044
4-Amino-5-oxo-8-(beta-D-xylofuranosyl)pyrido[2,3-d]pyrimidine (4) was recently synthesized and evaluated in our laboratories for anticancer activities. This compound showed potent in vitro inhibitory effects on the growth of HTB-81 prostate cancer cells and...
4.
Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska M, et al.
Blood
. 2001 May;
97(10):3075-85.
PMID: 11342433
The aim of this study was to explore further the hypothesis that early stages of normal human hematopoiesis might be coregulated by autocrine/paracrine regulatory loops and by cross-talk among early...
5.
Gunic E, Girardet J, Pietrzkowski Z, Esler C, Wang G
Bioorg Med Chem
. 2001 Feb;
9(1):163-70.
PMID: 11197336
Toyocamycin and some analogues have shown potent antitumor activities; however, none of them could be used clinically primarily owing to their cytotoxicity to normal human cells. In order to overcome...
6.
Majka M, Rozmyslowicz T, Ratajczak J, Dobrowsky A, Pietrzkowski Z, Gaulton G, et al.
Exp Hematol
. 2001 Jan;
28(12):1334-42.
PMID: 11146155
The resistance of human bone marrow (BM) CD34(+) cells to human immunodeficiency virus (HIV) infection is at this point not fully understood. Recently we reported that the chemokines MIP-1alpha, MIP-1beta,...
7.
Drabek K, Pesic M, Piperski V, Ruzdijic S, Medic-Mijacevic L, Pietrzkowski Z, et al.
Anticancer Drugs
. 2000 Dec;
11(9):765-70.
PMID: 11129740
Compounds that could block tumor angiogenesis and induce tumor cell differentiation in malignant gliomas represent a very valuable tool in anticancer treatments. In this paper, we demonstrate that more selective...
8.
Girardet J, Gunic E, Esler C, Cieslak D, Pietrzkowski Z, Wang G
J Med Chem
. 2000 Oct;
43(20):3704-13.
PMID: 11020285
A number of nucleoside analogues have been either used clinically as anticancer drugs or evaluated in clinical studies, while new nucleoside analogues continue to show promise. In this article, we...
9.
Pesic M, Drabek K, Esler C, Ruzdijic S, Pejanovic V, Pietrzkowski Z
Nucleosides Nucleotides Nucleic Acids
. 2000 Jul;
19(5-6):963-75.
PMID: 10893715
8-Cl-cAMP and tiazofurin (TR) are anti-tumor agents that besides their antiproliferative effect, also induce differentiation of tumor cells. Although, these agents exert a profound effect on the same events of...
10.
Majka M, Rozmyslowicz T, Lee B, MURPHY S, Pietrzkowski Z, Gaulton G, et al.
J Clin Invest
. 1999 Dec;
104(12):1739-49.
PMID: 10606628
CD34(+) cells are nonpermissive to infection by HIV strains X4 and R5, despite the fact that many CD34(+) cells express high levels of the viral receptor protein CD4 and the...